Helene Highbarger

发表

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Michael L. Nelson, Brad T. Sherman, I. Douglas, 2023, The Lancet Respiratory Medicine.

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

Kamil H A Kim, A. Ginde, R. Paredes, 2022, Annals of Internal Medicine.

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

Christina C. Chang, J. Thakuria, N. Gerry, 2022, The Lancet.

Genotypic Resistance at Viral Rebound Among Patients Who Received Lopinavir/Ritonavir-Based or Efavirenz-Based First Antiretroviral Therapy in South Africa

D. Follmann, R. Dewar, L. Morris, 2011, Journal of acquired immune deficiency syndromes.

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

Brad J. Wood, M. Proschan, R. Dewar, 2013, JAMA.

Comparison of the Abbott 7000 and Bayer 340 Systems for Measurement of Hepatitis C Virus Load

R. Dewar, J. Metcalf, M. Polis, 2007, Journal of Clinical Microbiology.

Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma.

R. Dewar, R. Davey, J. Kovacs, 1994, The Journal of infectious diseases.

Natural Occurring Non-Synonymous Single Nucleotide Polymorphisms in Integrase and RNase H Regulate Assembly and Autoprocessing of HIV-1

Jun Yang, R. Dewar, H. Lane, 2021, bioRxiv.

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Karla P. Zepeda, Christina C. Chang, Kamil H A Kim, 2022, Annals of Internal Medicine.

Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.

M. Proschan, R. Lempicki, Jun Yang, 2007, AIDS research and human retroviruses.

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels

Samuel M. Brown, Christina C. Chang, W. Self, 2021, Annals of Internal Medicine.

Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir‐Ritonavir

D. Follmann, R. Dewar, Zonghui Hu, 2011, Pharmacotherapy.

Towards Better Precision Medicine: PacBio Single-Molecule Long Reads Resolve the Interpretation of HIV Drug Resistant Mutation Profiles at Explicit Quasispecies (Haplotype) Level

Liang Ma, Castle Raley, Brad T. Sherman, 2015, Journal of data mining in genomics & proteomics.

Quantitation of Viremia and Determination of Drug Resistance in Patients with Human Immunodeficiency Virus Infection

R. Dewar, V. Natarajan, T. Elbeik, 2006 .

Comparison of the Quantiplex Version 3.0 Assay and a Sensitized Amplicor Monitor Assay for Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma Samples

R. Dewar, J. Metcalf, H. Lane, 1999, Journal of Clinical Microbiology.